Market Overview

Social Media Beat: What Experts And The Crowd Think Of Biotechs, GE And Tesla

Social Media Beat: What Experts And The Crowd Think Of Biotechs, GE And Tesla

  • What people say about stocks and the market on social media has become very important within investing.
  • This is why Market Prophit compiles and analyzes social media commentary related to the stock market and general investing, and then elaborates statistics that track sentiment for both experts (Market Prophits) and the public (the Crowd).
  • On Friday, Benzinga spoke with Market Prophit’s CEO Igor Gonta, who shared some commentary about trending stocks.
  • Biotechs

    When asked about Biotechs, Gonta responded, “After a period of recent pain, biotechs seem to have found a temporary floor.”

    He assured that both the Crowd and Market Prophits’ sentiment on iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) was “trending negative sentiment before the fall but has recently reversed course, with the Market Prophits strongly bullish.”

    General Electric

    Gonta then went into General Electric Company (NYSE: GE), which “beat earnings and is looking at Digital/Industrial M&A as a potential area of focus and expansion.”

    Related Link: Social Media Beat: The Three Gs -- GE, Google And Gilead

    “The Crowd is currently bearish but the Market Prophits are bullish,” he added.


    Finally, the expert looked into Tesla Motors Inc (NASDAQ: TSLA), and noted that while the stock “recently hit a speed bump after announcing its Model X, sentiment has recently started to diverge dramatically between the Crowd and Market Prophits. While the Crowd remains bearish, the Market Prophits are strongly bullish.”

    Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.

    Image Credit: Public Domain

    Posted-In: Biotech Crowdsourcing Top Stories Exclusives Tech Trading Ideas ETFs General Best of Benzinga


    Related Articles (IBB + GE)

    View Comments and Join the Discussion!
    Lightning Fast
    Market News Service
    $199 Free 14 Day Trial

    Dormant Debt Epidemic Leaves Afflicted Financially Unprepared

    Jim Cramer Sees More Problems Ahead For Oilfield Companies, Cites Schlumberger's Q3 Report